nach oben

Reactions Weekly

Erschienen in:

01.07.2023 | Case report

Antineoplastics

Lymphoproliferative disorders and lack of efficacy: 36 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Gion Y, et al. PD-L1 expression is associated with the spontaneous regression of patients with methotrexate-associated lymphoproliferative disorders. Cancer Medicine 11 : 417-432, No. 2, Jan 2022. Available from: URL: http://doi.org/10.1002/cam4.4462

Titel: Antineoplastics
Lymphoproliferative disorders and lack of efficacy: 36 case reports
Publikationsdatum: 01.07.2023
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-43508-3

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Tozinameran

Atezolizumab

Mesalazine

Societal burden of opioid toxicity-related deaths in the US worsened during COVID-19 pandemic

Bevacizumab

Denosumab